Desvenlafaxine as a Potential First-Line Treatment for Major Depressive Disorder: A Comprehensive Review and Consensus-Based Clinical Perspective on Efficacy, Safety and Patient Selection Profiles.

Saved in:
Bibliographic Details
Title: Desvenlafaxine as a Potential First-Line Treatment for Major Depressive Disorder: A Comprehensive Review and Consensus-Based Clinical Perspective on Efficacy, Safety and Patient Selection Profiles.
Authors: Carmassi C; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy., Correll CU; Department of Child and Adolescent Psychiatry, Universitätsmedizin Charité Berlin, Berlin, Germany.; Department of Psychiatry and Molecular Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA.; Northwell, New Hyde Park, NY, USA., de Diego-Adeliño J; Psychiatry Department, Hospital de la Santa Creu i Sant Pau, Carrer de Sant Quintí, 89, 08041, Barcelona, Spain. fdiego@santpau.cat.; Mental Health Research Group, Institut de Recerca Sant Pau (IR-Sant Pau), Barcelona, Spain. fdiego@santpau.cat.; Department of Psychiatry and Legal Medicine, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain. fdiego@santpau.cat.; Centro de Investigación Biomédica en Red (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain. fdiego@santpau.cat., Vian-Lains A; Highfield Healthcare, Dublin, Ireland., Oliveira C; Psychiatric Clinic, Hospital Júlio de Matos (ULS São José), Avenida do Brasil, n.º 53, 1700-063, Lisbon, Portugal. cirooliveira@ulssjose.min-saude.pt., Schneider-Pérez A; Global Medical Affairs Department, Neuraxpharm, Barcelona, Catalonia, Spain., Sharma VM; Global Medical Affairs Department, Neuraxpharm, Barcelona, Catalonia, Spain.
Source: Clinical drug investigation [Clin Drug Investig] 2026 Jul 06. Date of Electronic Publication: 2026 Jul 06.
Publication Type: Journal Article; Review
Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9504817 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1918 (Electronic) Linking ISSN: 11732563 NLM ISO Abbreviation: Clin Drug Investig Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42410139
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Desvenlafaxine as a Potential First-Line Treatment for Major Depressive Disorder: A Comprehensive Review and Consensus-Based Clinical Perspective on Efficacy, Safety and Patient Selection Profiles.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Carmassi+C%22">Carmassi C</searchLink>; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.<br /><searchLink fieldCode="AU" term="%22Correll+CU%22">Correll CU</searchLink>; Department of Child and Adolescent Psychiatry, Universitätsmedizin Charité Berlin, Berlin, Germany.; Department of Psychiatry and Molecular Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA.; Northwell, New Hyde Park, NY, USA.<br /><searchLink fieldCode="AU" term="%22de+Diego-Adeliño+J%22">de Diego-Adeliño J</searchLink>; Psychiatry Department, Hospital de la Santa Creu i Sant Pau, Carrer de Sant Quintí, 89, 08041, Barcelona, Spain. fdiego@santpau.cat.; Mental Health Research Group, Institut de Recerca Sant Pau (IR-Sant Pau), Barcelona, Spain. fdiego@santpau.cat.; Department of Psychiatry and Legal Medicine, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain. fdiego@santpau.cat.; Centro de Investigación Biomédica en Red (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain. fdiego@santpau.cat.<br /><searchLink fieldCode="AU" term="%22Vian-Lains+A%22">Vian-Lains A</searchLink>; Highfield Healthcare, Dublin, Ireland.<br /><searchLink fieldCode="AU" term="%22Oliveira+C%22">Oliveira C</searchLink>; Psychiatric Clinic, Hospital Júlio de Matos (ULS São José), Avenida do Brasil, n.º 53, 1700-063, Lisbon, Portugal. cirooliveira@ulssjose.min-saude.pt.<br /><searchLink fieldCode="AU" term="%22Schneider-Pérez+A%22">Schneider-Pérez A</searchLink>; Global Medical Affairs Department, Neuraxpharm, Barcelona, Catalonia, Spain.<br /><searchLink fieldCode="AU" term="%22Sharma+VM%22">Sharma VM</searchLink>; Global Medical Affairs Department, Neuraxpharm, Barcelona, Catalonia, Spain.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229504817%22">Clinical drug investigation</searchLink> [Clin Drug Investig] 2026 Jul 06. <i>Date of Electronic Publication: </i>2026 Jul 06.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Adis%2C+Springer+International%22">Adis, Springer International </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>9504817 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1179-1918 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2211732563%22">11732563 </searchLink><i>NLM ISO Abbreviation: </i>Clin Drug Investig <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42410139
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s40261-026-01576-6
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Desvenlafaxine as a Potential First-Line Treatment for Major Depressive Disorder: A Comprehensive Review and Consensus-Based Clinical Perspective on Efficacy, Safety and Patient Selection Profiles.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Carmassi C
      – PersonEntity:
          Name:
            NameFull: Correll CU
      – PersonEntity:
          Name:
            NameFull: de Diego-Adeliño J
      – PersonEntity:
          Name:
            NameFull: Vian-Lains A
      – PersonEntity:
          Name:
            NameFull: Oliveira C
      – PersonEntity:
          Name:
            NameFull: Schneider-Pérez A
      – PersonEntity:
          Name:
            NameFull: Sharma VM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 06
              M: 07
              Text: 2026 Jul 06
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1179-1918
          Titles:
            – TitleFull: Clinical drug investigation
              Type: main
ResultId 1